These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2749609)

  • 21. Potentiation of ADP-induced aggregation in human platelet-rich plasma by 5-hydroxytryptamine and adrenaline.
    Vanags DM; Rodgers SE; Duncan EM; Lloyd JV; Bochner F
    Br J Pharmacol; 1992 Aug; 106(4):917-23. PubMed ID: 1393289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet aggregation in recombinant-hirudin-anticoagulated blood.
    Glusa E
    Haemostasis; 1991; 21 Suppl 1():116-20. PubMed ID: 1909991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1-O-hexadecyl-2-acetyl-sn-3-glycerophosphorylcholine (PAF): some effects on the aggregation of human platelets by thrombin or collagen.
    Hornby EJ; Perry CR
    Thromb Haemost; 1983 Aug; 50(2):586-7. PubMed ID: 6636035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of cyclooxygenase-independent platelet aggregation by low vitamin E concentration.
    Violi F; Pratico D; Ghiselli A; Alessandri C; Iuliano L; Cordova C; Balsano F
    Atherosclerosis; 1990 Jun; 82(3):247-52. PubMed ID: 2115784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet-activating factor (PAF-acether) and microcirculation: effect of Lyso-PAF and PAF-antagonists.
    Lagente V; Fortes ZB; Garcia-Leme J; Vargaftig BB
    Braz J Med Biol Res; 1987; 20(5):595-7. PubMed ID: 3452452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effects of the new PAF acether antagonist WEB-2086 on pharmacologic changes induced by PAF inhalation in human beings.
    Adamus WS; Heuer HO; Meade CJ; Schilling JC
    Clin Pharmacol Ther; 1990 Apr; 47(4):456-62. PubMed ID: 2328553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of platelet activating factor, thromboxane A2 and leukotrienes in guinea-pig heart.
    Piper PJ; Yaacob HB
    Prog Clin Biol Res; 1989; 301():493-8. PubMed ID: 2508116
    [No Abstract]   [Full Text] [Related]  

  • 28. The action of platelet activating factor and its antagonism by WEB 2086 on human isolated airways.
    Johnson PR; Armour CL; Black JL
    Eur Respir J; 1990 Jan; 3(1):55-60. PubMed ID: 2311732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet activation by cultured mouse peritoneal macrophages.
    Blumenthal KM; Rourke FJ; Wilder MS
    J Reticuloendothel Soc; 1980 Mar; 27(3):247-57. PubMed ID: 7365732
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of cutaneous and platelet responses to platelet-activating factor by oral WEB 2086 in man.
    Hayes JP; Ridge SM; Griffith S; Barnes PJ; Chung KF
    J Allergy Clin Immunol; 1991 Jul; 88(1):83-8. PubMed ID: 2071787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological modulation of Paf-induced rat pleurisy and its role in inflammation by zymosan.
    Martins MA; Silva PM; Faria Neto HC; Bozza PT; Dias PM; Lima MC; Cordeiro RS; Vargaftig BB
    Br J Pharmacol; 1989 Feb; 96(2):363-71. PubMed ID: 2924083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of PAF-induced histamine secretion and bronchoconstriction by WEB 2086.
    Chand N; Pillar J; Nolan K; Diamantis W; Sofia RD
    Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):155-8. PubMed ID: 1691522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the stimulation of human blood platelets by semi-synthetic platelet-activating factor.
    Ostermann G; Till U; Thielmann K
    Thromb Res; 1983 Apr; 30(2):127-36. PubMed ID: 6408754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety, tolerability, and pharmacologic activity of multiple doses of the new platelet activating factor antagonist WEB 2086 in human subjects.
    Adamus WS; Heuer H; Meade CJ; Brecht HM
    Clin Pharmacol Ther; 1989 Mar; 45(3):270-6. PubMed ID: 2920502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of platelet-activating factor in hypotension and platelet activation induced by infusion of thrombolytic agents in rabbits.
    Montrucchio G; Alloatti G; Mariano F; Lupia E; Lucchina PG; Musso E; Emanuelli G; Camussi G
    Circ Res; 1993 Mar; 72(3):658-70. PubMed ID: 8381725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [3H]WEB 2086 labels platelet activating factor receptors in guinea pig and human lung.
    Dent G; Ukena D; Sybrecht GW; Barnes PJ
    Eur J Pharmacol; 1989 Oct; 169(2-3):313-6. PubMed ID: 2553451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of platelet-activating factor (PAF) on porcine pulmonary vessels in vitro.
    Pritze S; Simmet T; Peskar BA
    Prog Clin Biol Res; 1989; 301():481-5. PubMed ID: 2798458
    [No Abstract]   [Full Text] [Related]  

  • 38. Platelet-activating factor induces eosinophil peroxidase release from purified human eosinophils.
    Kroegel C; Yukawa T; Dent G; Chanez P; Chung KF; Barnes PJ
    Immunology; 1988 Jul; 64(3):559-61. PubMed ID: 3410498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ADP-, PAF- and adrenaline-induced platelet aggregation and thromboxane formation are not affected by a thromboxane receptor antagonist at physiological external Ca++ concentrations.
    Bretschneider E; Glusa E; Schrör K
    Thromb Res; 1994 Aug; 75(3):233-42. PubMed ID: 7992234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PAF-receptors on eosinophils: identification with a novel ligand, [3H]WEB 2086.
    Ukena D; Krogel C; Dent G; Yukawa T; Sybrecht G; Barnes PJ
    Biochem Pharmacol; 1989 May; 38(10):1702-5. PubMed ID: 2543419
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.